Department of Biotechnology, Hamdard University, Hamdard Nagar, New Delhi, 110062, India.
Protoplasma. 2013 Apr;250(2):483-93. doi: 10.1007/s00709-012-0431-5. Epub 2012 Jul 7.
The effect of an aqueous extract of Origanum vulgare (OV) leaves extract on CCl4-induced hepatotoxicity was investigated in normal and hepatotoxic rats. To evaluate the hepatoprotective activity of OV, rats were divided into six groups: control group, O. vulgare group, carbon tetrachloride (CCl4; 2 ml/kg body weight) group, and three treatment groups that received CCl4 and OV at doses of 50, 100, 150 mg/kg body weight orally for 15 days. Alanine amino transferase (ALT), alkaline phosphatase (ALP), and aspartate amino transferase (AST) in serum, lipid peroxide (LPO), GST, CAT, SOD, GPx, GR, and GSH in liver tissue were estimated to assess liver function. CCl4 administration led to pathological and biochemical evidence of liver injury as compared to controls. OV administration led to significant protection against CCl4-induced hepatotoxicity in dose-dependent manner, maximum activity was found in CCl4 + OV3 (150 mg/kg body weight) groups and changes in the hepatocytes were confirmed through histopathological analysis of liver tissues. It was also associated with significantly lower serum ALT, ALP, and AST levels, higher GST, CAT, SOD, GPx, GR, and GSH level in liver tissue. The level of LPO also decreases significantly after the administration of OV leaves extract. The biochemical observations were supplemented with histopathological examination of rat liver sections. Thus, the study suggests O. vulgare showed protective activity against CCl4-induced hepatotoxicity in Wistar rats and might be beneficial for the liver toxicity.
研究了牛至(Origanum vulgare)叶水提物对正常和肝毒性大鼠四氯化碳(CCl4)诱导的肝毒性的影响。为了评价牛至的保肝活性,将大鼠分为六组:对照组、牛至组、CCl4(2 ml/kg 体重)组和三个治疗组,它们分别接受 CCl4 和牛至 50、100、150 mg/kg 体重的口服剂量,治疗 15 天。血清丙氨酸氨基转移酶(ALT)、碱性磷酸酶(ALP)和天冬氨酸氨基转移酶(AST)、肝组织脂质过氧化物(LPO)、GST、CAT、SOD、GPx、GR 和 GSH 用于评估肝功能。与对照组相比,CCl4 给药导致了明显的病理和生化证据的肝损伤。牛至给药以剂量依赖性方式对 CCl4 诱导的肝毒性产生显著保护作用,在 CCl4+OV3(150 mg/kg 体重)组中发现最大活性,并且通过对肝组织的组织病理学分析证实了肝细胞的变化。同时,血清 ALT、ALP 和 AST 水平显著降低,肝组织中 GST、CAT、SOD、GPx、GR 和 GSH 水平显著升高,LPO 水平也显著降低。牛至叶提取物的给药还伴有大鼠肝组织切片的组织病理学检查。因此,该研究表明牛至对 Wistar 大鼠的 CCl4 诱导的肝毒性具有保护作用,可能对肝毒性有益。